Literature DB >> 9215654

Comparison of serum and plasma viral RNA measurements in primary and chronic human immunodeficiency virus type 1 infection.

R J Rodriguez1, D E Dayhoff, G Chang, S A Cassol, D L Birx, A W Artenstein, N L Michael.   

Abstract

We sought to define the relation between serum and plasma HIV-1 viral RNA load in patients with primary and chronic HIV-1 disease. HIV-1 viral load was determined from 116 serum and plasma samples, including 33 matched pairs, from five patients with primary and three patients with chronic HIV disease using the Roche HIV Monitor assay. The mean +/- standard deviations of the serum and plasma viral RNA levels from the 33 matched pairs were 4.372 +/- 0.885 and 4.478 +/- 0.950 log10 (copies/ml), respectively. This -0.106 log difference between serum and plasma viral RNA levels, which equates to 21% of non-log-transformed values, was not statistically significant by the Wilcoxon sign rank test (p = 0.09). The distributions of serum and plasma viral load slopes, calculated from all available viral RNA load data for each patient, were also not statistically different (p = 0.07). The levels of HIV-1 RNA measured in the serum or plasma of HIV-seropositive patients yield equivalent biologic information.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215654     DOI: 10.1097/00042560-199705010-00008

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  8 in total

1.  Efficient quantification of HIV-1 in heparin plasma spiked with cultured HIV-1 by the Roche Cobas TaqMan and Abbott RealTime HIV-1 tests.

Authors:  Linda L Jagodzinski; Holly R Weston; Ying Liu; Robert J O'Connell; Sheila A Peel
Journal:  J Clin Microbiol       Date:  2012-06-06       Impact factor: 5.948

Review 2.  Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics.

Authors:  J Lew; P Reichelderfer; M Fowler; J Bremer; R Carrol; S Cassol; D Chernoff; R Coombs; M Cronin; R Dickover; S Fiscus; S Herman; B Jackson; J Kornegay; A Kovacs; K McIntosh; W Meyer; N Michael; L Mofenson; J Moye; T Quinn; M Robb; M Vahey; B Weiser; T Yeghiazarian
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

3.  Understanding the effects of different HIV transmission models in individual-based microsimulation of HIV epidemic dynamics in people who inject drugs.

Authors:  J F G Monteiro; D J Escudero; C Weinreb; T Flanigan; S Galea; S R Friedman; B D L Marshall
Journal:  Epidemiol Infect       Date:  2016-01-12       Impact factor: 2.451

4.  Associations of common variants in the BST2 region with HIV-1 acquisition in African American and European American people who inject drugs.

Authors:  Dana B Hancock; Nathan C Gaddis; Joshua L Levy; Laura J Bierut; Alex H Kral; Eric O Johnson
Journal:  AIDS       Date:  2015-04-24       Impact factor: 4.177

5.  Immunologic and virologic events in early HIV infection predict subsequent rate of progression.

Authors:  Anuradha Ganesan; Pratip K Chattopadhyay; Tess M Brodie; Jing Qin; Wenjuan Gu; John R Mascola; Nelson L Michael; Dean A Follmann; Mario Roederer
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

6.  Higher parental occupational social contact is associated with a reduced risk of incident pediatric type 1 diabetes: Mediation through molecular enteroviral indices.

Authors:  Anne-Louise Ponsonby; Angela Pezic; Fergus J Cameron; Christine Rodda; Andrew S Kemp; John B Carlin; Heikki Hyoty; Amirbabak Sioofy-Khojine; Terence Dwyer; Justine A Ellis; Maria E Craig
Journal:  PLoS One       Date:  2018-04-17       Impact factor: 3.240

Review 7.  Overview of the Analytes Applied in Genotypic HIV Drug Resistance Testing.

Authors:  Hezhao Ji; Paul Sandstrom
Journal:  Pathogens       Date:  2022-06-29

8.  Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative review.

Authors:  Eline L Korenromp; Brian G Williams; George P Schmid; Christopher Dye
Journal:  PLoS One       Date:  2009-06-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.